Biomarkers Poster lunch Poster Display session

48P - Genetic association of matrix metalloproteinase MMP- 1, MMP-3 and MMP-9 genes with HCV-related hepatocellular carcinoma in Egyptian patients (ID 985)

Presentation Number
48P
Presentation Topic
Biomarkers
Lecture Time
13:00 - 13:00
Speakers
  • A. Alhanafy
Authors
  • A. Alhanafy
  • B. Montaser
  • W. Fathy
  • N. Elabd
  • S. Tayel
Session Title
Session Room
Exhibition area, Singapore, Singapore, Singapore
Date
18.11.2017
Session Time
13:00 - 14:00

Abstract

Background

Hepatocellular carcinoma (HCC) is one of the most frequent cancers in Egypt in which there is high prevalence of hepatitis C virus (HCV) infection. Matrix metalloproteinases (MMPs) are multifunctional proteins that assume an urgent part in cell development, differentiation, inflammation and angiogenesis. MMPs gene polymorphism might be included in development of HCV-related HCC. The study expected to explore relationship of MMP-1,3 & 9 genes polymorphisms with liver cirrhosis and HCC patients.

Methods

This study included 128 individuals who were enrolled from Menoufia University Hospital in the period between October 2015 and August 2016 classified into the following; Group I: included 48 patients with HCC on top of liver cirrhosis, they were 26 males and 22 females with mean age (58.60±5.29); Group II: 50 patients with liver cirrhosis, they were 26 males and 24 females with mean age (56.74±5.21); and Group III: 30 healthy subjects as controls, they were 15 males and 15 females with mean age (56.30 ±7.30). Diagnosis of HCC was done by their characteristic features in two imaging methods (abdominal US & triphasic CT). All subjects except controls were positive for serum HCV RNA. Liver functions tests, AFP & CHILD score were assessed. Genes polymorphisms were made by PCR-RFLP.

Results

HCC patients had higher mutant G2G2 (35.4%) and G2 allele (62.5%) of MMP-1 gene than both cirrhotic (P < 0.05) and control groups (P < 0.001). For MMP-3 gene, additionally, HCC patients had the most noteworthy predominance of mutant 5A/5A (22.9%) and 5A allele (52.1%) than both cirrhotic (P < 0.05) and control groups (P < 0.001). The results of MMP-9 gene uncovered higher frequency of mutant TT genotype and T allele in both HCC (56.3% and 74%, respectively) and cirrhotic groups (10% and 35%, respectively) than in the control group. In HCC patients, we detected a significant correlation between heterozygote G1/G2 and G2/G2 of MMP-1 gene and homozygote TT of MMP-9 with higher CHILD score, tumor size and stage (P < 0.05). Moreover, MMP-3 5A/6A had higher CHILD score, portal vein thrombosis and advanced stage (P < 0.05) compared with other genotypes.

Conclusions

MMP-1, 3, 9 gene mutation may be embroiled in progression of liver cirrhosis and hazard relationship for HCC development.

Legal entity responsible for the study

Menoufia University

Funding

None

Disclosure

All authors have declared no conflicts of interest.

Collapse